Navigation Links
RIPE Pilot Study Suggests Resveratrol May Improve Cognitive Function In The Elderly
Date:11/27/2012

SAN DIEGO, Nov. 27, 2012 /PRNewswire/ -- Findings from the "Resveratrol for Improved Performance in Elders" (RIPE) trial were presented last week at the 65th Annual Scientific Meeting of The Gerontological Society of America, which was hosted at the San Diego Convention Center from November 14 – 18.  The conference offered more than 400 scientific sessions to over 4,000 leaders in the field of aging from around the world.

The RIPE pilot study, a double-blind, placebo-controlled trial conducted by researchers at the University of Florida in Gainesville, followed cognitively intact men and women who orally ingested Resveratrol (provided by Reserveage Organics) in either 300 mg/d or 1000 mg/d doses over a 90-day period. Cognitive assessments were made at baseline and at the end of the study (Day 90) using: Hopkins Verbal Learning Test (HVLT), Digits Forward and Backward (DFB), Controlled Oral Word Association (COWA), Trail Making Tests (TMT: A & B), Digit Symbol Copy number (DSCN), and Digit Symbol Substitution Test (DSST).

Compared to placebo, Resveratrol supplementation taken in the 1000 mg/d dose improved psychomotor (processing) speed and significantly increased hippocampal activation (increased blood flow to the brain). Resveratrol, a natural polyphenolic compound present in various dietary sources including peanuts, grapes, red wine, and Japanese knotweed, has demonstrated a wide range of physiological benefits in humans.

"Our findings are supportive of a short-term course of Resveratrol supplementation for enhancing psychomotor speed and increasing hippocampal activation. We also observed exciting trends suggesting memory was improved," said lead researcher Steve Anton, Ph.D.,** from the Dept. of Aging and Geriatric Research and Institute on Aging at the University of Florida. "The results are very promising and show that Resveratrol may have a predictable positive impact on cognitive function in older adults."

The RIPE study, summarized in a poster presentation was supported by the McKnight Brain Research Foundation at the University of Florida; the NIH/NIA Claude D. Pepper Center; and Thomas H. Maren Foundation. Reserveage Organics, which provided Resveratrol supplements for the study, is based in Gainesville, Florida.  
**Steve Anton, Ph.D. periodically serves as a consultant for Reserveage Organics.


'/>"/>
SOURCE Reserveage Organics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bluechiip Receives First Sales Order from ATCC after Completion of Successful Pilot Trial
2. In Pilot Study, a Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism
3. Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study for the Treatment of Glaucoma
4. Systagenix begins pilot with ToolsGroup to optimise inventory levels
5. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
6. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
7. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
8. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
9. Shingles Vaccine is Safe, According to New Study
10. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
11. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... Feb. 21, 2017  /PR Newswire/ -- UBM Medica,s ... announce the launch of Modern Retina ( ... retina specialists. Built upon the success of ... on the latest innovations in the areas of retinal ... management. By meeting current informational needs and filling existing ...
(Date:2/21/2017)... , Feb. 21, 2017   BeyondSpring ... on the development of innovative immuno-oncology cancer therapies, ... significant data from its Phase 2 trial of ... the treatment of non-small cell lung cancer (NSCLC) ... at this year,s ASCO-SITC Clinical Immuno-Oncology Symposium in ...
(Date:2/21/2017)... IDAHO FALLS, Idaho , Feb. 21, 2017 /PRNewswire/ ... is has completed a private placement with certain investors ... preferred stock of the Company, Series C Convertible Redeemable ... Stock accrues dividends at an annual rate of 6% ... share.  The Company plans to use the proceeds for ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... 20, 2017 , ... MRI screening improves early diagnosis of breast cancer in ... online in the journal Radiology . , MRI has long been known ... ultrasound. Currently, guidelines reserve breast MRI screening for women who have a strong family ...
(Date:2/20/2017)... ... , ... Scrubbing in for his first esophageal cancer case in the late ... of the surgeon training him. , “He was giddy and almost couldn’t contain himself ... but I would do it for free,’” Dr. Pezzi recalled. “He genuinely was so ...
(Date:2/20/2017)... ... , ... The StayWell Company and VUCA Health announced ... risks, foster behavior change and improve health literacy among patients. VUCA Health, which created ... of its video capability at StayWell booth 3443 during HiMSS. , The VUCA ...
(Date:2/20/2017)... ... ... Population Health Software Company, is pleased to announce a move to a larger office building ... size of the previous location while bringing life back to a medical practice building that ... excited to expand our footprint to better serve our growing client base. We are ...
(Date:2/20/2017)... ... February 20, 2017 , ... Today, Illuma Care Connections, a ... during the 2017 Annual HIMSS Conference & Exhibition in Orlando, Florida, ... and integrating eye care into mainstream healthcare delivery is powered by Secure ...
Breaking Medicine News(10 mins):